More than 16,000 doses of Ervebo vaccine arrive in Ebola-hit DR Congo
Summary
The Democratic Republic of the Congo has received over 16,000 doses of the Ervebo vaccine to fight its deadliest Ebola outbreak. The vaccine targets the Zaire strain, but the current outbreak involves the Bundibugyo strain, for which no approved vaccine exists yet.Key Facts
- 16,250 doses of the Ervebo vaccine arrived in Kinshasa, the DRC capital.
- The World Health Organization and partners pledged a total of 70,000 vaccine doses for the country.
- The Bundibugyo strain is currently spreading in the DRC and has no approved vaccine or treatment.
- Early animal studies suggest Ervebo might offer some protection against the Bundibugyo strain.
- Of the 70,000 doses, 20,000 will be part of a clinical trial to test effectiveness against Bundibugyo.
- The rest of the doses are for frontline and healthcare workers.
- The outbreak has caused over 2,500 deaths and nearly 5,300 confirmed cases.
- Armed conflict, delayed case identification, and poor infrastructure make controlling the outbreak harder.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
